Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.

Pneumocystis carinii pneumonia is often the terminal event for patients with the acquired immunodeficiency syndrome. Eflornithine (DL-alpha-difluoromethylornithine [DFMO]; Ornidyl; Merrell Dow Research Institute, Cincinnati, Ohio) has been used successfully against this protozoan disease in limited...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Clarkson, A B, Williams, D E, Rosenberg, C
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1988
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172369/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3142346/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.8.1158
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!